You are here

dialysis

DaVita, Medtronic to study arrhythmia in dialysis patients

Mass Device

Tue, 11/18/14 - 11:02 am

Rockwell Dialysis Therapy Wins Panel Support But Final FDA Approval? Not So Fast.

TheStreet.com

Fri, 11/7/14 - 08:48 am

Rockwell Medical

advisory panels

FDA Review of Rockwell's Dialysis Therapy Raises Doubts About Need

TheStreet.com

Tue, 11/4/14 - 10:26 am

Rockwell Medical

DaVita's Acquisitions Look Promising, High Debt a Concern

Yahoo/Zacks.com

Fri, 10/3/14 - 10:00 am

U.S. justices decline to hear dialysis machine patent case

Yahoo/Reuters

Mon, 05/19/14 - 10:45 am

Baxter International

DaVita Spared as Medicare Wipes Out 9.4% Dialysis Cut

Bloomberg

Sat, 11/23/13 - 12:00 pm

Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex

Seeking Alpha

Mon, 11/11/13 - 11:39 am

Rockwell Medical: Significant Growth Potential With New State-Of-The-Art Dialysis Drug

Seeking Alpha

Wed, 11/6/13 - 11:23 am

Rockwell Medical

Soluble Ferric Pyrophosphate

3 Drug Classes That May Become Obsolete Within 3 Years

Motley Fool

Sun, 09/15/13 - 12:26 pm

type 2 diabetes

3 Things You Need to Know from Keryx's Stifel Conference Presentation

Motley Fool

Sat, 09/14/13 - 11:02 am

chronic kidney disease

hyperphosphatemia

Rockwell Medical: Expecting Good Cruise II Data In September

Seeking Alpha

Wed, 09/4/13 - 09:16 am

Rockwell Medical

Down 85%! Why Affymax Is Getting Crushed This Morning

Motley Fool

Mon, 02/25/13 - 09:50 am

Medicare to adjust payment for dialysis drugs after overspending millions

Washington Post, DC

Fri, 02/1/13 - 11:34 am

Daxor Announces Basic Blood Volume Research Study on Renal Dialysis Patients

Thu, 11/8/12 - 10:45 pm

DaVita agrees to pay $55 million to settle suit over Epogen overuse

Yahoo/AP

Thu, 07/5/12 - 01:20 pm

Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis

Mon, 05/28/12 - 10:15 am

Baxter International

clinical trials

KAI Pharmaceuticals Announces Initiation of Second Phase 2 Study of KAI-4169

BusinessWire

Sat, 01/7/12 - 02:32 pm

KAI Pharmaceuticals

Diabetes Epidemic Ruining Kidneys in India Spurs Fresenius Dialysis Sales

Wed, 12/28/11 - 04:44 pm

Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011

Yahoo/BusinessWire

Sat, 11/12/11 - 12:16 pm

chronic kidney disease

Fresenius lands two dialysis acquisitions for $2.1 billion | Acquisitions roundup

Fri, 08/5/11 - 12:05 am

Pages